Bioequivalence For Sprinkle Generics Needs Single-Dose Crossover Study
Executive Summary
ANDAs for drugs intended to be mixed into special foods or beverages should include a separate bioequivalence comparison to reference drug in a single-dose crossover study, FDA said in its final 1guidance for industry on "Food-Effect Bioavailability and Fed Bioequivalence Studies.